Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm
暂无分享,去创建一个
B. Abdullah | F. Izzo | M. Sherman | R. Lencioni | N. Borys | Guan-Tarn Huang | Yu Wang | S. C. F. Wong | W. Tak | J. Zheng | C. Peng | R. Xu | R. Poon | Shi-Ming Lin | Sy Park | M. Chen | Juemei Wang | J. Lee | Y. Chiou | Jmf Lee